1. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen
H: Classification of papillomaviruses. Virology 2004, 324:17-27.
2. zur Hausen H: Papillomaviruses and cancer: from basic studies
to clinical application. Nat Rev Cancer 2002, 2:342-50.
3. Palefsky J: Human papillomavirus and anal neoplasia. Curr
HIV/AIDS Rep 2008, 5:78-85.
4. Dianzani C, Calvieri S, Pierangeli A, Degener AM: Identification
of human papilloma viruses in male dysplastic genital lesions.
New Microbiol 2004, 27:65-9.
5. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F,
Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, et al: Human
papillomavirus and oral cancer: the International Agency for
Research on Cancer multicenter study. J Natl Cancer Inst 2003,
95:1772-83.
6. Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ,
Madeleine MM, Mao EJ, Fitzgibbons ED, Huang S, Beckmann
AM, et al: Oral cancer risk in relation to sexual history and
evidence of human papillomavirus infection. J Natl Cancer Inst
1998, 90:1626-36.
7. D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch
WM, Westra WH,
Gillison ML: Case-control study of human papillomavirus and
oropharyngeal cancer. N Engl J Med 2007, 356:1944-56.
8. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague
X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification
of human papillomavirus types associated with cervical cancer. N
Engl J Med 2003, 348:518-27.
9. Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF,
Wideroff L, Unger ER, Nisenbaum RA, Reeves WC, Icenogle JP:
Human papillomavirus (HPV) DNA copy number is dependent on
grade of cervical disease and HPV type. J Clin Microbiol 1999,
37:1030-4.
10. Kreimer AR, Clifford GM, Snijders PJ, Castellsague X,
Meijer CJ, Pawlita M, Viscidi R, Herrero R, Franceschi S: HPV16
semiquantitative viral load and serologic biomarkers in oral and
oropharyngeal squamous cell carcinomas. Int J Cancer 2005,
115:329-32.
11. Tucker RA, Unger ER, Holloway BP, Swan DC: Real-
time PCR-based fluorescent assay for quantitation of human
papillomavirus types 6, 11, 16, and 18. Mol Diagn 2001, 6:39-47.
12. Swan DC, Tucker RA, Holloway BP, Icenogle JP: A sensitive,
type-specific, fluorogenic probe assay for detection of human
papillomavirus DNA. J Clin Microbiol 1997, 35:886-91.
13. Peitsaro P, Johansson B, Syrjanen S: Integrated human
papillomavirus type 16 is frequently found in cervical cancer
precursors as demonstrated by a novel quantitative real-time PCR
technique. J Clin Microbiol 2002, 40:886-91.
14. Nagao S, Yoshinouchi M, Miyagi Y, Hongo A, Kodama J,
Itoh S, Kudo T: Rapid and sensitive detection of physical status
of human papillomavirus type 16 DNA by quantitative real-time
PCR. J Clin Microbiol 2002, 40:863-7.
15. Josefsson A, Livak K, Gyllensten U: Detection and quantitation
of human papillomavirus by using the fluorescent 5’ exonuclease
assay. J Clin Microbiol 1999, 37:490-6.
16. Gravitt PE, Peyton C, Wheeler C, Apple R, Higuchi R,
Shah KV: Reproducibility of HPV 16 and HPV 18 viral load
quantitation using TaqMan real-time PCR assays. J Virol Methods
2003, 112:23-33.